A Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate Cancer

NCT 06830850

Brief Introduction

To evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of 5041-103 in Subjects with Metastatic Castration-resistant Prostatea walnut-shaped gland in the male reproductive system that is responsible for producing semen - a bodily fluid that acts as a vessel for sperm transport during ejaculation Cancera disease where abnormal cells split without control and spread to other nearby body tissue and/or organs.

Intervention/Treatment

• Drug: HRS-5041 Single dosethe amount of medication taken of HRS-5041 orally administered

Inclusion Criteria

1. Ability to understand the trial procedures and possible adverse events, voluntarily participate in the trial.
2. Adequate bone marrowsoft, spongy tissue found in bones that makes blood cells and other vital organ functions
3. Adequate liver function tests
4. Metastatic Castration-resistant Prostate Cancer